| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/30/2007 | CN1969857A Mosapride citrate capsule and preparation process thereof |
| 05/30/2007 | CN1969856A Usage of caffeine and its analogue in resistance of hepatitis B replication and use thereof in preparation of medicament for treating viral hepatitis |
| 05/30/2007 | CN1969847A Pharmaceutical composition |
| 05/30/2007 | CN1969843A Application of allantoin in preparation of medicament for treating gallbladder disease and gastrointestinal convulsion |
| 05/30/2007 | CN1969838A Micro-ecological preparation for treating moniliasis |
| 05/30/2007 | CN1969833A Dry powder composition containing CoQ10 and preparation process thereof |
| 05/30/2007 | CN1318573C Mycobacterium smegmatis preparation and use thereof |
| 05/30/2007 | CN1318565C Health care wine |
| 05/30/2007 | CN1318439C Preparation method of amygdalin and its application in preparation of amygdalin preparation for promoting the blood circulation of heart, brain, pancreas and wound |
| 05/30/2007 | CN1318416C Indazole amide compounds as 5-serotoninergic agents |
| 05/30/2007 | CN1318414C Compound containing structure of o-naphthaquinone and application |
| 05/30/2007 | CN1318403C Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 05/30/2007 | CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 05/30/2007 | CN1318088C Oral cavity plastering sheet of interferon and its preparation method |
| 05/30/2007 | CN1318086C Use of soluble CTLA4 molecule in preparation of medicine composition for treating rheumatic diseases |
| 05/30/2007 | CN1318072C Anti-senility oral liquor |
| 05/30/2007 | CN1318069C Shuanghuang Zhenbei powder medicine |
| 05/30/2007 | CN1318051C Compound medicine with function of relaxing the bowels, and its preparation method |
| 05/30/2007 | CN1318050C Chinese medicine for treating hepatitis B and preparation method thereof |
| 05/30/2007 | CN1318041C Compositions for weight reduction |
| 05/30/2007 | CN1318036C 钙铝混悬液 Calcium aluminum suspension |
| 05/30/2007 | CN1318026C Solid pharmaceutical formulations comprising modafinil |
| 05/30/2007 | CN1318024C Beta-cyclodextrin/phenylpropanol inclusion and its preparing method |
| 05/30/2007 | CN1318021C Rapidly disintegrating table and process for manufacture thereof |
| 05/29/2007 | US7223867 Preparation of benzosuberonylpiperidine compounds |
| 05/29/2007 | US7223858 Truncated aggrecanase molecules |
| 05/29/2007 | US7223839 Splice variants of the human H3 histamine receptor having deletions of portions of the N-terminal of the wild type H3 receptor; useful in methods for identifying agonists, inverse agonists or antagonists of histamine action at the H3 receptor; therapeutic and diagnostic agents; nervous system disorders |
| 05/29/2007 | US7223798 treating inflammatory or autoimmune disorders and pulmonary or respiratory tract inflammation |
| 05/29/2007 | US7223794 For example, 2-{[(1S)-2-amino-1-phenylethyl]oxy}-4-chloro-5-fluorobenzonitrile; use in treatment or prophylaxis of inflammatory diseases and CNS diseases |
| 05/29/2007 | US7223784 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
| 05/29/2007 | US7223781 Immunomoderators; autoimmune disease; drug, cosmetics; antiinflammatory agnets |
| 05/29/2007 | US7223778 5-substituted-2-arylpyridines |
| 05/29/2007 | US7223777 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents |
| 05/29/2007 | US7223772 Cyclooxygenase-2 inhibitors (COX-2); 4-[2-(3-fluoro-phenyl)-6-trifluoromethyl-pyrazolo[1,5-a]pyridin-3-yl]benzenesulfonamide for example; fever, pain, inflammation, neurodegenerative disorders, oral diseases, influenza, arthritis, allergies |
| 05/29/2007 | US7223771 Inhibit the secretion of gastric acid; methyl 2,3-dimethyl-9-(2-ethyl-6-methyl-phenyl)-7H-8,9-dihydro-pyrano[2,3-c]-imidazo[1,2-a]pyridine-6-carboxylate for example; gastrointestinal inflammatory diseases such as gastric ulcers; high selectivity of action, side effect reduction, good enteral activity |
| 05/29/2007 | US7223760 Substituted triazole compounds |
| 05/29/2007 | US7223758 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 05/29/2007 | US7223751 Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 05/29/2007 | US7223741 nucleic acids containing unmethylated cytosine-guanine (CpG) dinucleotides activate lymphocytes in a subject and redirect a subject's immune response from a Th2 to a Th1 |
| 05/29/2007 | US7223732 Polypeptides; wound healing agents, antiulcer agents |
| 05/29/2007 | US7223591 Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 05/29/2007 | US7223394 Human antibodies that bind human TNFα |
| 05/29/2007 | CA2340052C Pharmaceutical compositions containing lipase inhibitors and chitosan |
| 05/29/2007 | CA2268758C Immunogenic detoxified mutant e. coli lt-a toxin |
| 05/29/2007 | CA2214565C New cryptophycins from synthesis |
| 05/24/2007 | WO2007059515A2 Compositions of lipoxygenase inhibitors |
| 05/24/2007 | WO2007059250A2 Plant-based formulations for improving liver health |
| 05/24/2007 | WO2007058995A1 Manually actuated contactless card |
| 05/24/2007 | WO2007058894A2 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 05/24/2007 | WO2007058523A1 Composition with docosapentaenoic acid |
| 05/24/2007 | WO2007058392A1 Heterocyclic compound and medicinal application thereof |
| 05/24/2007 | WO2007058322A1 Basic group-containing compound and use thereof |
| 05/24/2007 | WO2007058027A1 Harmful bacterium control agent containing bacillus thuringiensis |
| 05/24/2007 | WO2007056817A1 Pharmacologically active compounds containing sulfur |
| 05/24/2007 | WO2007020078A3 Rotavirus vaccine inducing heterotypic cross protection |
| 05/24/2007 | US20070117843 Quinoline inhibitors of cGMP phosphodiesterase |
| 05/24/2007 | US20070117812 3,5-Difluoro-2-pyridinecarboxamidine; intermediate for preparing dihydropyrimidines for the treatment and prophylaxis of hepatitis B |
| 05/24/2007 | US20070117790 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/24/2007 | US20070117758 Treating treating angiogenic disease, e.g., cancer, by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 05/24/2007 | US20070117754 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 05/24/2007 | US20070117165 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/24/2007 | US20070117160 Novel method of screening |
| 05/24/2007 | US20070117129 Antigen arrays for treatment of bone disease |
| 05/24/2007 | US20070117091 Anti-candida agents for the treatment of prion diseases |
| 05/24/2007 | US20070116721 Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof |
| 05/24/2007 | US20070116688 Methods of organ regeneration |
| 05/24/2007 | US20070116684 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070116683 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | US20070116682 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 05/24/2007 | DE60119515T2 Probiotica für verwendung als haustierfutter Probiotics for use as petfood |
| 05/24/2007 | DE102006013624A1 Glucose isomerase optionally in combination with 5-D-fructose-dehydrogenase, useful in/as medicine (product) for treating or diagnosing fructose intolerance |
| 05/24/2007 | CA2629323A1 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 05/24/2007 | CA2628630A1 Compositions of lipoxygenase inhibitors |
| 05/23/2007 | EP1788390A1 Screening method |
| 05/23/2007 | EP1788000A1 Agent for preventing and ameliorating obesity |
| 05/23/2007 | EP1787992A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 05/23/2007 | EP1787991A1 PYRROLOÝ2,3-c¨PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE |
| 05/23/2007 | EP1787986A1 Hydroxamic acid derivative and medicine containing the same as active ingredient |
| 05/23/2007 | EP1786416A1 Sulpiride derivatives pharmaceutical compositions |
| 05/23/2007 | EP1786410A2 The treatment of inflammatory disorders and pain |
| 05/23/2007 | EP1442040B1 Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists |
| 05/23/2007 | EP1369419B1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
| 05/23/2007 | EP1363885B1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 05/23/2007 | EP1237845B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 05/23/2007 | EP1181014B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 05/23/2007 | EP1037539B2 Method for accelerating protein digestion rate and its use |
| 05/23/2007 | CN1968932A Processes for preparing 6-alkyl-5-arylsulfonyl-dihydrophenanthridines |
| 05/23/2007 | CN1966521A Suppressing peptide of heptitis B virus polymerase lymerase protein YMDD functionalized area and its uses |
| 05/23/2007 | CN1966514A Novel acyclic nucleoside phosphonate and its medical use |
| 05/23/2007 | CN1966484A New phenoxy eicosanoic acid derivative and its medical use |
| 05/23/2007 | CN1966078A Therapeutic vaccine composition for hepatitis B |
| 05/23/2007 | CN1966077A Orally administered vaccine of hepatitis E and preparation process thereof |
| 05/23/2007 | CN1966065A Chinese herbal pill for treating hepatitis B |
| 05/23/2007 | CN1966058A Drink for preventing miscarriage |
| 05/23/2007 | CN1966054A Chinese medicinal prescription for expelling toxins to nourish face |
| 05/23/2007 | CN1966040A Chinese medicinal decoction for treating gastrointestinal diseases |
| 05/23/2007 | CN1966039A Chinese medicine for treating hepatitis B and preparation method thereof |
| 05/23/2007 | CN1966037A Medicament for harmonizing middle energizer, invigorating spleen and regulating stomach function |
| 05/23/2007 | CN1966036A Chinese medicine for treating gastrointestinal disease and preparation method thereof |
| 05/23/2007 | CN1966032A Tablet with seven kinds of ingredients for treating stomach ache and preparation process thereof |